Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

In vitro lytic activity and antifungal susceptibility of infrequently isolated yeasts.

Montoya AM, Luna-Rodríguez CE, Gracia-Robles G, Rojas OC, González GM.

Arch Microbiol. 2019 May 30. doi: 10.1007/s00203-019-01684-2. [Epub ahead of print]

PMID:
31147748
2.

In vitro virulence determinants, comparative pathogenicity of Diutina (Candida) mesorugosa clinical isolates and literature review of the D. rugosa complex.

Montoya AM, Luna-Rodríguez CE, Gracia-Robles G, Rojas OC, Treviño-Rangel RJ, González GM.

Mycologia. 2019 May-Jun;111(3):395-407. doi: 10.1080/00275514.2019.1585161. Epub 2019 Apr 15.

PMID:
30985256
3.

In vivo evaluation of the antifungal activity of sertraline against Aspergillus fumigatus.

Treviño-Rangel RJ, Villanueva-Lozano H, Méndez-Galomo KS, Solís-Villegas EM, Becerril-García MA, Montoya AM, Robledo-Leal ER, González GM.

J Antimicrob Chemother. 2019 Mar 1;74(3):663-666. doi: 10.1093/jac/dky455.

PMID:
30403787
4.

First report of Candida bracarensis in Mexico: hydrolytic enzymes and antifungal susceptibility pattern.

Treviño-Rangel RJ, Espinosa-Pérez JF, Villanueva-Lozano H, Montoya AM, Andrade A, Bonifaz A, González GM.

Folia Microbiol (Praha). 2018 Jul;63(4):517-523. doi: 10.1007/s12223-018-0592-5. Epub 2018 Feb 27.

PMID:
29488180
5.

Phenotypical characterization and molecular identification of clinical isolates of Candida tropicalis.

Treviño-Rangel RJ, Bodden-Mendoza BA, Montoya AM, Villanueva-Lozano H, Elizondo-Zertuche M, Robledo-Leal E, González GM.

Rev Iberoam Micol. 2018 Jan - Mar;35(1):17-21. doi: 10.1016/j.riam.2017.05.002. Epub 2017 Dec 26.

PMID:
29287631
6.

Biofilm formation and antifungal susceptibility of Trichosporon asahii isolates from Mexican patients.

Montoya AM, Elizondo-Zertuche M, Treviño-Rangel RJ, Becerril-García M, González GM.

Rev Iberoam Micol. 2018 Jan - Mar;35(1):22-26. doi: 10.1016/j.riam.2017.02.008. Epub 2017 Dec 26.

PMID:
29287630
7.

In vivo pathogenicity of Trichosporon asahii isolates with different in vitro enzymatic profiles in an immunocompetent murine model of systemic trichosporonosis.

Montoya AM, Luna-Rodríguez CE, Treviño-Rangel RJ, Becerril-García M, Ballesteros-Elizondo RG, Saucedo-Cárdenas O, González GM.

Med Mycol. 2018 Jun 1;56(4):434-441. doi: 10.1093/mmy/myx057.

PMID:
28992352
8.

Comparative Pathogenicity of Lomentospora prolificans (Scedosporium prolificans) Isolates from Mexican Patients.

Elizondo-Zertuche M, Montoya AM, Robledo-Leal E, Garza-Veloz I, Sánchez-Núñez AL, Ballesteros-Elizondo R, González GM.

Mycopathologia. 2017 Aug;182(7-8):681-689. doi: 10.1007/s11046-017-0137-5. Epub 2017 Apr 29.

PMID:
28456868
9.

Cytokines profile in immunocompetent mice during Trichosporon asahii infection.

Montoya AM, González GM, Martinez-Castilla AM, Aguilar SA, Franco-Molina MA, Coronado-Cerda E, Rosas-Taraco AG.

Med Mycol. 2018 Jan 1;56(1):103-109. doi: 10.1093/mmy/myx018.

PMID:
28340200
10.

Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients.

Montoya AM, Sánchez González A, Palma-Nicolás JP, Gómez-Treviño A, González JG, González GM.

Med Mycol. 2015 Jun;53(5):505-11. doi: 10.1093/mmy/myv009. Epub 2015 May 14.

PMID:
25980003

Supplemental Content

Loading ...
Support Center